Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
115.00    -2.50 (-2.13%)
Bid:
113.00
Ask:
115.00
Spread: 2.00 (1.77%)
Market Cap: £90.24m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Manufacturing rationalisation

1 Apr 2009 07:00

RNS Number : 8292P
Xaar PLC
01 April 2009
Β 

ο»Ώ

FOR IMMEDIATE RELEASE

1 AprilΒ 2009

Xaar plc

RATIONALISATION OF MANUFACTURING FACILITIES

100 NEW HIGH TECHNOLOGY JOBS TO BE CREATED IN THE UK

Xaar plc ("Xaar"Β or "the Company"), the inkjet printing technology group headquartered in Cambridge,Β can confirm that it will now proceed with the rationalisation of its manufacturing facilities.

As part of the proposed rationalisation, approximately 100 new jobsΒ willΒ be created atΒ the Company'sΒ 'state of the art'Β Huntingdon plant over the period of the transfer.

Further to theΒ disclosureΒ of the proposal in the final results announcement on 23 March 2009, the period of consultation withΒ the representatives of the workforce of approximately 130 at the Company's Swedish manufacturing facility in JΓ€rfΓ€lla, near Stockholm,Β has nowΒ ended. Accordingly,Β Xaar's Board has decided to proceed withΒ rationalising its production of printheads by transferring manufacturing from the plant in Sweden to its facility in Huntingdon, near Cambridge, and the eventual closure of the JΓ€rfΓ€lla facility. The process is expected to take about two years to complete in a phased transfer to ensure minimal disruption to the business and continued availability of finished product.

As stated previously,Β theΒ transferΒ isΒ expected to achieve:

a substantial reduction in manufacturing costs;
a reduction in management overhead;
better use of production capacity;
improved operational efficiency; andΒ 
the elimination of exchange rate exposure between Sterling and the Swedish Krona.

Ian Dinwoodie, Xaar's Chief Executive, commented:

"We plan to fund the relocation of our Swedish manufacturingΒ activitiesΒ to HuntingdonΒ with a mix of cash generated from our operations and some external equipment finance. We aim to preserve our cash balances and strong balance sheet."

Ends

Β 

CONTACTS

Xaar plc:
01223-423663
Ian Dinwoodie, Chief Executive
www.xaar.com
Andrew Taylor, Finance Director
Β 
Β 
Β 
Bankside Consultants:
Β 
Steve Liebmann or Simon Bloomfield
020-7367-8883 / 07802-888159

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCMGGFFFMLGLZM
Date   Source Headline
1st Jul 20221:10 pmRNSTotal Voting Rights
21st Jun 20225:20 pmRNSDirector Declaration - Additional Directorship
1st Jun 202210:22 amRNSTotal Voting Rights
25th May 20221:57 pmRNSResult of AGM
3rd May 20225:20 pmRNSTotal Voting Rights
7th Apr 20226:31 pmRNSPDMR Shareholding
7th Apr 20222:50 pmRNSGrant of Options and Deferred Bonus Share Awards
1st Apr 202210:48 amRNSTotal Voting Rights
29th Mar 20227:00 amRNS2021 Full Year Results
28th Mar 202210:44 amRNSHolding(s) in Company
21st Mar 202212:37 pmRNSNotice of 2021 Preliminary Results
3rd Mar 20227:00 amRNSAcquisition of Megnajet
1st Mar 20225:29 pmRNSTotal Voting Rights
1st Feb 20225:00 pmRNSTotal Voting Rights
18th Jan 20224:35 pmRNSPrice Monitoring Extension
13th Jan 20227:00 amRNSTrading Update
4th Jan 20222:39 pmRNSBlock listing Interim Review
4th Jan 20222:37 pmRNSTotal Voting Rights
10th Dec 20214:23 pmRNSGrant of Awards - Replacement
6th Dec 202112:25 pmRNSHolding(s) in Company
1st Dec 20215:00 pmRNSTotal Voting Rights
5th Nov 202110:30 amRNSGrant of Sharesave Options
1st Nov 20214:11 pmRNSCompletion of Divestment of Xaar 3D
1st Nov 20211:56 pmRNSTotal Voting Rights
29th Oct 20214:41 pmRNSSecond Price Monitoring Extn
29th Oct 20214:36 pmRNSPrice Monitoring Extension
25th Oct 202110:38 amRNSResult of General Meeting
15th Oct 202111:50 amRNSGrant of Options and Deferred Bonus Share Awards
14th Oct 20218:44 amRNSBlock Listing Application
13th Oct 20212:52 pmRNSHolding(s) in Company
6th Oct 20212:43 pmRNSPublication of Circular and Notice of GM
6th Oct 20217:00 amRNSProposed divestment of Xaar 3D
1st Oct 202111:59 amRNSTotal Voting Rights
14th Sep 20217:00 amRNS2021 Interim Results
3rd Sep 202112:59 pmRNSNotice of 2021 Interim Results
2nd Sep 20213:40 pmRNSTotal Voting Rights
2nd Aug 20215:02 pmRNSTotal Voting Rights
22nd Jul 20217:00 amRNSTrading Update
12th Jul 20217:00 amRNSAcquisition of FFEI
1st Jul 20213:20 pmRNSBlock listing Interim Review
1st Jul 202110:51 amRNSTotal Voting Rights
22nd Jun 20215:37 pmRNSHolding(s) in Company
22nd Jun 202111:44 amRNSHolding(s) in Company
16th Jun 20211:17 pmRNSResult of AGM
1st Jun 202110:10 amRNSTotal Voting Rights
17th May 20219:27 amRNSHolding(s) in Company
12th May 202110:15 amRNSHolding(s) in Company
4th May 20213:01 pmRNSTotal Voting Rights
30th Apr 20216:23 pmRNSAnnual Financial Report
27th Apr 20217:00 amRNS2020 FULL YEAR RESULTS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.